Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
3.205
-0.015 (-0.47%)
Aug 14, 2025, 1:48 PM - Market open
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $1.87 million as of August 14, 2025. Its market cap has decreased by -77.46% in one year.
Market Cap
1.87M
Enterprise Value
-4.26M
1-Year Change
-77.46%
Ranking
Category
Stock Price
$3.21
Market Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.48M to $1.87M, a decrease of -99.42%. That is a compound annual growth rate of -75.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 1.88M | -79.89% |
| Dec 31, 2024 | 9.34M | -88.50% |
| Dec 29, 2023 | 81.20M | -75.83% |
| Dec 30, 2022 | 335.90M | 3.73% |
| Dec 31, 2021 | 323.81M | 0.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 603.75B |
| Johnson & Johnson | 419.56B |
| AbbVie | 359.85B |
| UnitedHealth Group | 246.88B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 224.83B |